Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Goodwill (2020 - 2025)

Bioventus (BVS) has disclosed Goodwill for 6 consecutive years, with $7.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Goodwill changed N/A year-over-year to $7.5 million, compared with a TTM value of $7.5 million through Sep 2025, changed N/A, and an annual FY2024 reading of $7.5 million, changed 0.0% over the prior year.
  • Goodwill was $7.5 million for Q3 2025 at Bioventus, roughly flat from $7.5 million in the prior quarter.
  • Across five years, Goodwill topped out at $147.6 million in Q4 2021 and bottomed at $7.5 million in Q4 2022.
  • Average Goodwill over 5 years is $26.0 million, with a median of $7.5 million recorded in 2022.
  • The sharpest move saw Goodwill soared 196.43% in 2021, then tumbled 94.95% in 2022.
  • Year by year, Goodwill stood at $147.6 million in 2021, then crashed by 94.95% to $7.5 million in 2022, then changed by 0.0% to $7.5 million in 2023, then changed by 0.0% to $7.5 million in 2024, then changed by 0.0% to $7.5 million in 2025.
  • Business Quant data shows Goodwill for BVS at $7.5 million in Q3 2025, $7.5 million in Q2 2025, and $7.5 million in Q1 2025.